Literature DB >> 12079363

Folding and oxidation of the antibody domain C(H)3.

Michael J W Thies1, Fabio Talamo, Marcus Mayer, Stefan Bell, Margherita Ruoppolo, Gennaro Marino, Johannes Buchner.   

Abstract

The non-covalent homodimer formed by the C-terminal domains of the IgG1 heavy chains (C(H)3) is the simplest naturally occurring model system for studying immunoglobulin folding and assembly. In the native state, the intrachain disulfide bridge, which connects a three-stranded and a four-stranded beta-sheet is buried in the hydrophobic core of the protein. Here, we show that the disulfide bridge is not required for folding and association, since the reduced C(H)3 domain folds to a dimer with defined secondary and tertiary structure. However, the thermodynamic stability of the reduced C(H)3 dimer is much lower than that of the oxidized state. This allows the formation of disulfide bonds either concomitant with folding (starting from the reduced, denatured state) or after folding (starting from the reduced dimer). The analysis of the two processes revealed that, under all conditions investigated, one of the cysteine residues, Cys 86, reacts preferentially with oxidized glutathione to a mixed disulfide that subsequently interacts with the less-reactive second thiol group of the intra-molecular disulfide bond. For folded C(H)3, the second step in the oxidation process is slow. In contrast, starting from the unfolded and reduced protein, the oxidation reaction is faster. However, the overall folding reaction of C(H)3 during oxidative folding is a slow process. Especially, dimerization is slow, compared to the association starting from the denatured oxidized state. This deceleration may be due to misfolded conformations trapped by the disulfide bridge. (c) 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079363     DOI: 10.1016/S0022-2836(02)00375-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.

Authors:  Tianlei Ying; Weizao Chen; Yang Feng; Yanping Wang; Rui Gong; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

2.  Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.

Authors:  Thomas Spreter Von Kreudenstein; Eric Escobar-Carbrera; Paula I Lario; Igor D'Angelo; Karine Brault; John Kelly; Yves Durocher; Jason Baardsnes; R Jeremy Woods; Michael Hongwei Xie; Pierre-Alain Girod; Michael D L Suits; Martin J Boulanger; David K Y Poon; Gordon Y K Ng; Surjit B Dixit
Journal:  MAbs       Date:  2013-07-08       Impact factor: 5.857

Review 3.  How antibodies fold.

Authors:  Matthias J Feige; Linda M Hendershot; Johannes Buchner
Journal:  Trends Biochem Sci       Date:  2009-12-21       Impact factor: 13.807

4.  The mouse B cell-specific mb-1 gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.

Authors:  Richard Sims; Virginia Oberholzer Vandergon; Cindy S Malone
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

5.  Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment.

Authors:  Fang Zeng; Chunpeng Yang; Xinyu Gao; Xuan Li; Zhe Zhang; Rui Gong
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

6.  Increased aggregation propensity of IgG2 subclass over IgG1: role of conformational changes and covalent character in isolated aggregates.

Authors:  Heather Franey; Stephen R Brych; Carl G Kolvenbach; Rahul S Rajan
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

7.  Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain.

Authors:  Arnold McAuley; Jaby Jacob; Carl G Kolvenbach; Kimberly Westland; Hyo Jin Lee; Stephen R Brych; Douglas Rehder; Gerd R Kleemann; David N Brems; Masazumi Matsumura
Journal:  Protein Sci       Date:  2008-01       Impact factor: 6.725

8.  Complementary middle-down and intact monoclonal antibody proteoform characterization by capillary zone electrophoresis - mass spectrometry.

Authors:  Arseniy M Belov; Li Zang; Roberto Sebastiano; Marcia R Santos; David R Bush; Barry L Karger; Alexander R Ivanov
Journal:  Electrophoresis       Date:  2018-06-05       Impact factor: 3.535

9.  Construction of a stability landscape of the CH3 domain of human IgG1 by combining directed evolution with high throughput sequencing.

Authors:  Michael W Traxlmayr; Christoph Hasenhindl; Matthias Hackl; Gerhard Stadlmayr; Jakub D Rybka; Nicole Borth; Johannes Grillari; Florian Rüker; Christian Obinger
Journal:  J Mol Biol       Date:  2012-07-27       Impact factor: 5.469

10.  The reduced form of the antibody CH2 domain.

Authors:  Zhaoyong Xi; Xianglei Liu; Rui Lin; John D Persons; Tatiana V Ilina; Wei Li; Dimiter S Dimitrov; Rieko Ishima
Journal:  Protein Sci       Date:  2021-06-16       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.